慢性阻塞性肺病中的肠道微生物群因CT验证的肺状态而有所不同
Anders Ørskov Rotevatn1,2, Tomas Mikal Eagan1,2, Solveig Tangedal1,2
1Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.
与健康个体相比,慢性阻塞性肺病 (COPD) 患者的肠道微生物群不同,在肺中观察到明显的微生物差异. 拉克诺斯皮拉属 (Lachnospiraceae) 家族在COPD肠道失调症中显示出潜在的治疗意义.
科学领域:
- 微生物组研究的研究.
- 肺部医学 肺部医学
- 肠肺轴 肠肺轴 肠肺轴 肠肺轴
背景情况:
- 肠道微生物群在慢性阻塞性肺病 (COPD) 现型中的作用尚不清楚.
- 研究COPD患者与对照者的肠道微生物差异对于了解疾病机制至关重要.
研究的目的:
- 为了比较COPD患者和健康对照者的肠道微生物组合.
- 为了将肠道微生物发现与COPD表型 (如肺气,恶化率和肺功能) 相关联.
主要方法:
- 一项涉及62名COPD患者和49名对照者的病例控制研究.
- 便样本的16S rRNA基因测序以分析细菌组成.
- 差异丰度分析 (ANCOM-BC) 和贝塔多样性比较 (PERMANOVA).
主要成果:
- 在COPD患者中观察到减少的Veillonella和增加的Clostridia类属.
- 与对照组相比,在肺气患者中发现了微生物组成 (β多样性) 的显著差异.
- 27个属,包括来自Lachnospiraceae家族的9个属,在肺气中差异丰富;几个与肺功能相关.
结论:
- 肠道微生物群的组成在COPD和没有COPD的个体之间存在显著差异,肺气的变化更为明显.
- 拉赫诺斯皮拉属 (Lachnospiraceae) 需要进一步研究其在COPD病变发生过程中的作用,以及其作为治疗点的潜力.
更多相关视频
11:23Purifying the Impure: Sequencing Metagenomes and Metatranscriptomes from Complex Animal-associated Samples
Published on: December 22, 2014
08:14A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model
Published on: February 28, 2018
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
